pentobarbital will decrease the level or influence of ketoconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.

pentobarbital will lessen the extent or impact of aprepitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

Contraindicated (one)pentobarbital decreases amounts of vandetanib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Prevent coadministration with potent CYP3A4 inducers; these drugs decrease exposure to vandetanib by approximately 40%.

pentobarbital will decrease the level or result of parecoxib by impacting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Check.

pentobarbital will reduce the extent or outcome of zaleplon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.

pentobarbital boosts toxicity of ifosfamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. CYP3A4 inducers may perhaps improve the metabolism of ifosfamide to its Lively alkylating metabolites.

pentobarbital will reduce the extent or result of atorvastatin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

Check Intently (1)pentobarbital will minimize the extent or influence of cannabidiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will reduce the level or result of voriconazole by influencing hepatic enzyme CYP2C9/ten metabolism. Small/Significance Unknown.

pentobarbital will reduce the level or impact of nilotinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will lower the extent or effect of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Use of naloxegol with robust CYP3A4 inducers is just not recommended

pentobarbital will reduce the extent or impact of lopinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will lessen the level or outcome of fedratinib by impacting more info hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Influence of coadministering a powerful CYP3A4 inducer with fedratinib hasn't been studied.

pentobarbital will decrease the extent or impact of glecaprevir/pibrentasvir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.